Foster Jon M sold $15.9M of HCA

Foster Jon M (EVP and COO) sold 31,713 shares of HCA Healthcare, Inc. (HCA) at an average of $500.98 ($491.98–$514.07, $15.89M total) across 8 trades over 2026-11-04 to 2026-11-06.

Original reporting
SEC EDGAR · Foster Jon M
Published Nov 6, 2026, 10:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 10:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HCA
Bearish
high confidence
Mentioned
$HCA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HCABearishLow
01

Why it matters

The insider sell may prompt short‑term price weakness, but long‑term fundamentals remain unchanged.

02

Market read

The filing provides fresh, material information for traders monitoring HCA, with a modest bearish bias.

03

What to watch

Potential tax planning or liquidity needs for the executive; no direct operational concerns disclosed.

Relevance 6/10Novelty 7/10Timing: after-hours filing

Background

SEC Form 4 filings disclose insider transactions; a sale of this size by an EVP/COO is noteworthy.

Company-level read

Ticker impact

$HCABearishHigh confidence
Context

Form 4 shows EVP/COO Foster Jon M sold ~31,700 shares for $15.9M, reducing his stake to 10,000 shares.

Expected impact

likely downward pressure as market prices in the insider sell.

Evidence & confidence

The filing is the first public disclosure of a multi‑million dollar sale by a senior officer, which traders often view as a bearish signal.

Market effects

Minimal impact on the broader healthcare sector; isolated to HCA.

U.S. market only; no regional ripple.

Low; limited to investors tracking HCA.

Counterpoint

The sale could be a routine portfolio rebalancing unrelated to company fundamentals.

Key entities

  • Foster Jon M

    Executive Vice President and Chief Operating Officer of HCA Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$CNCMed

Health insurers, hospitals rally after sweeping midterm win for Democrats

Shares of Medicaid-focused health insurers (Centene, Elevance, Molina) and hospital operators (HCA, Tenet, Universal) rose after Democrats won the midterms, raising hopes for sector-friendly policies. Analysts expect delays in Trump's OBBBA, easing pressure on Medicaid and ACA insurers, and potential extensions of enhanced subsidies. Year-to-date gains vary among companies.

$TSLAHighAI 8/10

Tesla, SpaceX And AI Stocks Slide After Democrats Take Congress

Stock futures rose premarket after Democrats took control of Congress. Renewable energy and healthcare stocks gained, while AI-linked and Texas-based companies like Tesla (TSLA) and SpaceX fell. Oracle (ORCL) and Nvidia (NVDA) also declined on data center concerns. Trump Media & Technology Group (DJT) shares dropped 11%.